Skip to contentM
Myriad Genetics Inc
M
MYGNMyriad Genetics Inc Q1 2019 · 10-Q
Revenue$216.60M$216.60Mno prior Q1 2018 on file Net Income$6.90M$6.90Mno prior Q1 2018 on file EPS Diluted$0.09$0.09no prior Q1 2018 on file Operating Income$5,900,000— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$3,500,000— Margins · derivedOperating margin2.7%
Net margin3.2%
ended Mar 31, 2019 · filed May 8, 2019 · 38 d after period end